Brainmarkers.com

Brain Atrophy Indices: simple methods for assessing atrophy of brain structures on MRI

Pages

  • Home
  • Nomenclature
  • Articles
  • Posters and communications
  • Projects

Corpus Callosum as a biomarker of lobar degeneration

Corpus Callosum as a biomarker for Alzheimer and Multiple Sclerosis


Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease
Publicado por Unknown en 1:48 PM
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Etiquetas: Multiple Sclerosis, Parkinson

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)
Welcome to Brainmarkers.com

This blog is devoted to devising morphological indices suitable for the assessment of atrophy of brain structures in clinical practice.

Disorders

  • Alzheimer
  • Frontotemporal Lobe Dementia
  • MCI
  • Multiple Sclerosis
  • Parkinson
  • Parkinsonisms

Brain structures

  • Corpus Callosum
  • Gray Matter
  • Hippocampus
  • Parietal
  • Substantia innominata
  • Thalamus
  • Ventricular System
  • White matter

Indices

  • BV/CSF index
  • HVi
  • Hr
  • MTAi
  • MTL
  • MTLr
  • yrRTA

My research activity

  • Call for Contributions: New Book on Intrathecal Drug Delivery in the NEUROMETHODS Series by Springer Nature
  • Targeting soluble Abeta oligomers in the CSF via intrathecal pseudodelivery
  • Association between naturally occurring antiamyloid β autoantibodies and medial temporal lobe atrophy in Alzheimer’s disease
  • A role for ATXN1, ATXN2 and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease
  • The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population‐Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight
Related blogs

Alzheimer biomarkers

  • Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
  • Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease
  • Florbetaben PET imaging to detect amyloid plaques in Alzheimer disease: Phase 3 study
  • Predicting the risk of mild cognitive impairment
  • 7 Tesla MRI in Alzheimer's disease

Neuroimaging

Loading...
Simple theme. Powered by Blogger.